PGP and prostate carcinoma: We have shown here that the targeted inhibitors that were initially discovered through computational high throughput drug docking studies specifically inhibited P-glycoprotein function and increased the accumulation of P-gp transport substrates in 2- and 3-dimensional cell cultures of chemotherapy resistant ovarian and prostate cancer cell lines.